Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Camurus AB

Capitalization 27.97B 2.97B 2.59B 2.34B 2.24B 4.07B 274B 4.24B 11.09B 131B 11.13B 10.89B 473B P/E ratio 2025
50.2x
P/E ratio 2026 * 29.7x
Enterprise value 24.47B 2.59B 2.27B 2.05B 1.96B 3.56B 240B 3.7B 9.7B 115B 9.73B 9.53B 414B EV / Sales 2025
16.2x
EV / Sales 2026 * 8.38x
Free-Float
57.92%
Yield 2025 *
-
Yield 2026 * -
1 day-0.55%
1 week-2.62%
Current month-6.92%
1 month-15.41%
3 months-23.37%
6 months-35.99%
Current year-23.99%
1 week 465
Extreme 465
493.6
1 month 465
Extreme 465
565
Current year 465
Extreme 465
710
1 year 465
Extreme 465
754.5
3 years 197.6
Extreme 197.6
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 63 01/01/2002
Chairman 77 01/01/2015
Director/Board Member 61 07/05/2020
Change 5d. change 1-year change 3-years change Capi.($)
-0.55%-2.62%-22.68%+108.46% 2.97B
+0.80%-0.53%+21.09%+201.18% 880B
-0.21%+0.47%+48.34%+56.91% 582B
-2.52%-4.53%+3.74%+42.79% 388B
+0.79%-6.01%+4.87%+20.81% 324B
+0.11%-0.83%+19.89%+34.57% 295B
+0.43%-1.54%+25.96%+62.12% 293B
-0.26%-0.16%+22.25%+8.08% 286B
-0.43%-0.90%+16.74%+58.82% 197B
+0.42%+0.74%+30.11%+81.76% 180B
Average -0.14%-1.59%+17.03%+67.55% 342.91B
Weighted average by Cap. -0.02%-1.37%+22.81%+84.83%

Financials

2025 2026 *
Net sales 2.32B 246M 215M 194M 185M 337M 22.71B 351M 918M 10.85B 921M 902M 39.19B 2.81B 298M 261M 235M 225M 410M 27.57B 426M 1.11B 13.17B 1.12B 1.1B 47.58B
Net income 826M 87.59M 76.56M 69.17M 66.17M 120M 8.1B 125M 327M 3.87B 329M 322M 13.98B 903M 95.69M 83.64M 75.56M 72.29M 131M 8.85B 137M 358M 4.23B 359M 351M 15.27B
Net Debt -3.51B -372M -325M -293M -281M -511M -34.37B -531M -1.39B -16.42B -1.39B -1.36B -59.31B -4.41B -467M -409M -369M -353M -642M -43.23B -668M -1.75B -20.65B -1.75B -1.72B -74.59B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
285
Date Price Change Volume
13/03/26 468.20 kr -0.55% 85,675
12/03/26 470.80 kr -0.93% 71,442
11/03/26 475.20 kr -1.41% 71,907
10/03/26 482.00 kr +0.84% 173,565
09/03/26 478.00 kr -0.58% 112,728
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
468.20SEK
Average target price
768.00SEK
Spread / Average Target
+64.03%

Quarterly revenue - Rate of surprise

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW